Streetbeat News

Earnings

OGEN

Oragenics, Inc. (OGEN) has filed its annual report, highlighting progress in diversifying its product development portfolio, particularly in neurological disorders treatment. Key achievements include acquiring a technology for treating neurological disorders, raising funds through public and private offerings, hiring a Chief Medical Officer, adding new Board members, creating an Australian subsidiary for R&D rebates, and preparing for a Phase II clinical trial. However, the report includes a going concern note.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:09 pm

IRON

Disc Medicine shares dropped following the announcement of topline results from the Phase 2 AURORA study of bitopertin in patients with EPP.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:07 pm

VISL

Vislink Technologies shares are trading higher following the announcement of their Q4 results.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:06 pm

ALPN

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) announced it will present updated clinical data for povetacicept in IgA nephropathy at the World Congress of Nephrology 2024. The data comes from the RUBY-3 phase 1b/2a study. Concurrently, ALPN will host an investor event on April 15th.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:05 pm

LLY

Eli Lilly and Co (NYSE:LLY) has received mixed analyst ratings over the past three months, with a notable shift towards more bullish sentiments in recent evaluations. The average 12-month price target for LLY has been raised to $799.0, indicating a 12.89% increase from the previous target. Analysts from firms including Cantor Fitzgerald, Truist Securities, JP Morgan, and others have maintained or raised their ratings, with price targets ranging up to $1000.00. Eli Lilly's financial performance has been strong, with significant revenue growth, high net margin, and exceptional ROE and ROA, although its debt-to-equity ratio indicates a higher level of debt.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 1:00 pm

CNM

CVX

KLAC

LDOS

PFE

SFL

Jim Cramer discussed several companies on CNBC's 'Mad Money Lightning Round,' highlighting their recent performances and analyst ratings. Core & Main reported upbeat sales but missed earnings estimates slightly. KLA Corporation received a Buy rating from Stifel. Chevron is performing well with a 4% yield and a new MOU for CCS development. Pfizer, after acquiring Seagen, was downgraded by Argus Research. Leidos Holdings received a price target increase from B of A Securities. SFL Corporation posted better-than-expected results, but Cramer warned about overstaying in the stock.

Portfolio Pulse from Avi Kapoor

April 01, 2024 | 1:00 pm

DOMA

SGRP

UPS

Doma shares surged 40% following a merger announcement with TRG, going private at $6.29/share. SPAR Group's Q4 EPS rose to $0.11 from $0.08 YoY, with sales of $65.10M surpassing estimates. UPS shares increased by 2.28% after securing an air cargo contract with the United States Postal Service.

Portfolio Pulse from ryanfaloona@benzinga.com

April 01, 2024 | 12:55 pm

PVH

PVH Corp. (NYSE:PVH), the parent company of Calvin Klein and Tommy Hilfiger, is expected to report Q4 earnings of $3.52 per share, up from $2.38 the previous year, with revenue projected at $2.42 billion. The company declared a quarterly cash dividend of 3.75 cents per share, payable on March 27, 2024. To earn $500 monthly from dividends, an investment of approximately $5,624,400 or around 40,000 shares is needed. PVH shares gained 0.9% to close at $140.61 recently.

Portfolio Pulse from Avi Kapoor

April 01, 2024 | 12:53 pm

J

Jacobs Solutions Inc. (NYSE:J) announced Kevin Berryman as the interim CFO, succeeding Claudia Jaramillo. Berryman, a former CFO and current Special Advisor, takes over as Jaramillo departs to pursue other opportunities. The company is searching for a permanent CFO with an executive search firm's help. Jacobs reaffirmed its FY24 outlook, excluding costs from the separation of its CMS and Cyber & Intelligence businesses. The company will discuss FY24 updates and Q2 results on its May 7, 2024, earnings call.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:53 pm

BITF

Bitfarms Ltd (NASDAQ:BITF) shares are trading higher after the company released a production and operations update for March, reporting it mined 286 bitcoin, a decrease from previous months, but increased its total bitcoin holdings to 806. The company also announced the purchase of additional miners to reach a target of 21 EH/s by year-end, aiming for greater operating efficiency.

Portfolio Pulse from Adam Eckert

April 01, 2024 | 12:51 pm